Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Clonal hematopoiesis in elderly twins: concordance, discordance and mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Low vs. high hemoglobin trigger for Transfusion in Vascular surgery (TV): a randomized clinical feasibility trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The collagen receptor uPARAP/Endo180 regulates collectins through unique structural elements in its FNII domain

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. CCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Tine Wyseure
  • Esther J Cooke
  • Paul J Declerck
  • Niels Behrendt
  • Joost C M Meijers
  • Annette von Drygalski
  • Laurent O Mosnier
Vis graf over relationer

Joint bleeds are common in congenital hemophilia, but rare in acquired hemophilia A (aHA) for reasons unknown. To identify key mechanisms responsible for joint-specific bleeding in congenital hemophilia, bleeding phenotypes after joint injury and tail transection were compared in aHA wild-type mice (receiving an anti-FVIII antibody), and congenital hemophilia A (FVIII-/-) mice. Both aHA and FVIII-/- mice bled severely after tail transection, but consistent with clinical findings, joint bleeding was notably milder in aHA compared to FVIII-/- mice. Focus was directed to Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) to determine its potentially protective effect on joint bleeding in aHA. Joint bleeding in TAFI-/- mice with anti-FVIII antibody was increased, compared to wild-type aHA mice, and became indistinguishable from joint bleeding in FVIII-/- mice. Measurements of circulating TAFI zymogen consumption after joint injury indicated severely defective TAFI activation in FVIII-/- mice in vivo, consistent with previous in vitro analysis in FVIII-deficient plasma. In contrast, notable TAFI activation was observed in aHA mice, suggesting that TAFI protected aHA joints against bleeding. Pharmacological inhibitors of fibrinolysis revealed that urokinase Plasminogen Activator (uPA)-induced fibrinolysis drove joint bleeding, whereas tissue-type Plasminogen Activator (tPA)-mediated fibrinolysis contributed to tail bleeding. These data identify TAFI as an important modifier of hemophilic joint bleeding in aHA by inhibiting uPA-mediated fibrinolysis. Moreover, our data suggest that bleed protection by TAFI was absent in congenital FVIII-/- mice due to severely defective TAFI activation, underscoring the importance of clot protection in addition to clot formation when considering prohemostatic strategies for hemophilic joint bleeding.

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind132
Udgave nummer15
Sider (fra-til)1593-1603
ISSN0006-4971
DOI
StatusUdgivet - 11 okt. 2018

ID: 54960183